YTEN - Yield10 Bioscience, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD

Yield10 Bioscience, Inc.

19 Presidential Way
Woburn, MA 01801
United States

SectorBasic Materials
IndustrySpecialty Chemicals
Full Time Employees22

Key Executives

NameTitlePayExercisedYear Born
Dr. Oliver P. PeoplesCo-Founder, Pres, CEO & Director287.38kN/A1958
Dr. Anthony J. SinskeyCo-Founder & Director47.5kN/A1940
Dr. Kristi D. SnellVP of Research & Chief Science Officer238.97kN/A1968
Ms. Lynne H. BrumVP of Planning & Corp. Communications and Sec.237.52kN/A1964
Mr. Charles B. HaaserVP of Fin., Chief Accounting Officer & TreasurerN/AN/A1956
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company, through its Smart Carbon Grid for Crops and T3 platforms, is involved in improving fundamental crop yield through enhanced photosynthetic carbon capture, as well as increased carbon utilization efficiency to increase seed yield. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was founded in 1992 and is headquartered in Woburn, Massachusetts.

Corporate Governance

Yield10 Bioscience, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.